Mehow Medical announced on September 22 a draft 2026 restricted stock incentive plan, under which it intends to grant a total of 6.07 million restricted shares in one go, accounting for 0.76% of the company's total share capital, at a grant price of 8.49 yuan per share, with no reserved equity. The number of incentive recipients is no more than 496, all of whom are core employees of the company, and the maximum validity period of the incentive plan is no more than 36 months. In the first half of 2026, Mehow Medical achieved revenue of 813 million yuan and net profit attributable to the parent company of 124 million yuan.
MeHow Innovative Ltd. AMehow Medical plans to grant 6.07 million restricted shares at 8.49 yuan under a 2026 incentive plan, a capital/equity-compensation event with no clear directional impact.
